A new series of flurobenzothiazole incorporated 1, 3, 4 -thiadiazole compounds have been synthesized. The structure of the synthesized compounds was confirmed by UV, IR, 1 H NMR, Mass spectral analysis and evaluated for their antimicrobial activity against Proteus vulgaris NCTC 4635, Micrococcus leutus NL98, Aspergillus flavus ATCC 46646 by disc diffusion method. The compounds SH 8 and SH 11 were also evaluated for the antiinflammatory activity by carrageenan-induced paw oedema method. The synthesized compounds (SH 6 to SH 11 ) showed good antimicrobial activity. However the antimicrobial activity of the synthesized compounds against the tested organisms was found to be less than that of respective standard drugs used at tested dose level. The anti-inflammatory activity confirmed that the test compound SH 11 showed superior activity in the inhibition of oedema than SH 8. However, both the test compounds were found to be less active than the standard drug used.
INTRODUCTION:Research for the development of new therapeutic agents is becoming the major interest in many academic and industrial research laboratories all over the world with the aim to discover newer, more potent molecules, with higher specificity and reduced toxicity than the existing ones. In addition, the various types of resistant microorganisms that are discovered now-a-days are becoming a great challenge for the scientists. The existing drugs that are available are either very expensive or are prone to microbial resistance. Most of the drugs that are marketed today are modified derivatives of existing pharmacophores. No new pharmacophore having a novel mechanism of action has been identified in the recent past. To overcome these problems, it becomes necessary for further investigating newer molecules to treat infections at affordable costs.